Skip to main content

Network-based expression analysis reveals key genes related to glucocorticoid resistance in infant acute lymphoblastic leukemia

Abstract

Purpose

Despite vast improvements that have been made in the treatment of children with acute lymphoblastic leukemia (ALL), the majority of infant ALL patients (~80 %, < 1 year of age) that carry a chromosomal translocation involving the mixed lineage leukemia (MLL) gene shows a poor response to chemotherapeutic drugs, especially glucocorticoids (GCs), which are essential components of all current treatment regimens. Although addressed in several studies, the mechanism(s) underlying this phenomenon have remained largely unknown. A major drawback of most previous studies is their primary focus on individual genes, thereby neglecting the putative significance of inter-gene correlations. Here, we aimed at studying GC resistance in MLL-rearranged infant ALL patients by inferring an associated module of genes using co-expression network analysis. The implications of newly identified candidate genes with associations to other well-known relevant genes from the same module, or with associations to known transcription factor or microRNA interactions, were substantiated using literature data.

Methods

A weighted gene co-expression network was constructed to identify gene modules associated with GC resistance in MLL-rearranged infant ALL patients. Significant gene ontology (GO) terms and signaling pathways enriched in relevant modules were used to provide guidance towards which module(s) consisted of promising candidates suitable for further analysis.

Results

Through gene co-expression network analysis a novel set of genes (module) related to GC-resistance was identified. The presence in this module of the S100 and ANXA genes, both well-known biomarkers for GC resistance in MLL-rearranged infant ALL, supports its validity. Subsequent gene set net correlation analyses of the novel module provided further support for its validity by showing that the S100 and ANXA genes act as ‘hub’ genes with potentially major regulatory roles in GC sensitivity, but having lost this role in the GC resistant phenotype. The detected module implicates new genes as being candidates for further analysis through associations with known GC resistance-related genes.

Conclusions

From our data we conclude that available systems biology approaches can be employed to detect new candidate genes that may provide further insights into drug resistance of MLL-rearranged infant ALL cases. Such approaches complement conventional gene-wise approaches by taking putative functional interactions between genes into account.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. C.-H. Pui, M. V. Relling, J. R. Downing, Acute lymphoblastic leukemia. New Engl J Med 350, 1535–1548 (2004)

    CAS  Article  PubMed  Google Scholar 

  2. M. Greaves, Infant leukaemia biology, aetiology and treatment. Leukemia 10, 372–377 (1996)

    CAS  PubMed  Google Scholar 

  3. R. Pieters, M. Schrappe, P. De Lorenzo, I. Hann, G. De Rossi, M. Felice, L. Hovi, T. LeBlanc, T. Szczepanski, A. Ferster, A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet 370, 240–250 (2007)

    CAS  Article  PubMed  Google Scholar 

  4. R. Pieters, M. Den Boer, M. Durian, G. Janka, K. Schmiegelow, G. Kaspers, E. Van Wering, A. Veerman, Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia-implications for treatment of infants. Leukemia 12, 1344–1348 (1998)

    CAS  Article  PubMed  Google Scholar 

  5. H. Riehm, A. Reiter, M. Schrappe, F. Berthold, R. Dopfer, V. Gerein, R. Ludwig, J. Ritter, B. Stollmann, G. Henze, Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83). Klinische Padiatrie 199, 151–160 (1986)

    Article  Google Scholar 

  6. A. Holleman, M. H. Cheok, M. L. den Boer, W. Yang, A. J. Veerman, K. M. Kazemier, D. Pei, C. Cheng, C.-H. Pui, M. V. Relling, Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. New Engl J Med 351, 533–542 (2004)

    CAS  Article  PubMed  Google Scholar 

  7. R. W. Stam, M. L. Den Boer, P. Schneider, J. de Boer, J. Hagelstein, M. G. Valsecchi, P. de Lorenzo, S. E. Sallan, H. J. Brady, S. A. Armstrong, Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia. Blood 115, 1018–1025 (2010)

    CAS  Article  PubMed  Google Scholar 

  8. G. Wei, D. Twomey, J. Lamb, K. Schlis, J. Agarwal, R. W. Stam, J. T. Opferman, S. E. Sallan, M. L. den Boer, R. Pieters, Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance. Cancer Cell 10, 331–342 (2006)

    CAS  Article  PubMed  Google Scholar 

  9. J. A. Spijkers-Hagelstein, P. Schneider, S. M. Pinhanços, P. G. Castro, R. Pieters, R. W. Stam, Glucocorticoid sensitisation in mixed lineage leukaemia-rearranged acute lymphoblastic leukaemia by the pan-BCL-2 family inhibitors gossypol and AT-101. Eur J Cancer 50, 1665–1674 (2014)

    CAS  Article  PubMed  Google Scholar 

  10. N. Kaiser, I. S. Edelman, Calcium dependence of glucocorticoid-induced lymphocytolysis. Proc Natl Acad Sci USA 74, 638–642 (1977)

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  11. J. A. Spijkers-Hagelstein, P. Schneider, E. Hulleman, J. de Boer, O. Williams, R. Pieters, R. W. Stam, Elevated S100A8/S100A9 expression causes glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia. Leukemia 26, 1255–1265 (2012)

    CAS  Article  PubMed  Google Scholar 

  12. S. Qazi, F. M. Uckun, Gene expression profiles of infant acute lymphoblastic leukaemia and its prognostically distinct subsets. Br J Haematol 149, 865–873 (2010)

    CAS  Article  PubMed  Google Scholar 

  13. J. A. Spijkers-Hagelstein, S. M. Pinhancos, P. Schneider, R. Pieters, R. W. Stam, Src kinase-induced phosphorylation of annexin A2 mediates glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia. Leukemia 27, 1063–1071 (2013)

    CAS  Article  PubMed  Google Scholar 

  14. J. Spijkers-Hagelstein, S. Pinhanços, P. Schneider, R. Pieters, R. Stam, Chemical genomic screening identifies LY294002 as a modulator of glucocorticoid resistance in MLL-rearranged infant ALL. Leukemia 28, 761–769 (2014)

    CAS  Article  PubMed  Google Scholar 

  15. X. Wang, J. Wen, R. Li, G. Qiu, L. Zhou, X. Wen, Gene expression profiling analysis of castration-resistant prostate cancer. Med Sci Monitor 21, 205–212 (2014)

    CAS  Google Scholar 

  16. J. Y. Chen, Z. Yan, C. Shen, D. P. Fitzpatrick, M. Wang, A systems biology approach to the study of cisplatin drug resistance in ovarian cancers. J Bioinf Comput Biol 5, 383–405 (2007)

    Article  Google Scholar 

  17. B. C. Browne, F. Hochgräfe, J. Wu, E. K. Millar, J. Barraclough, A. Stone, R. A. McCloy, C. S. Lee, C. Roberts, N. A. Ali, Global characterization of signalling networks associated with tamoxifen resistance in breast cancer. FEBS J 280, 5237–5257 (2013)

    CAS  Article  PubMed  Google Scholar 

  18. J. Helleman, M. Smid, M. P. Jansen, M. E. van der Burg, E. M. Berns, Pathway analysis of gene lists associated with platinum-based chemotherapy resistance in ovarian cancer: the big picture. Gynecol Oncol 117, 170–176 (2010)

    CAS  Article  PubMed  Google Scholar 

  19. W. L. Allen, L. Stevenson, V. M. Coyle, P. V. Jithesh, I. Proutski, G. Carson, M. A. Gordon, H.-J. D. Lenz, S. Van Schaeybroeck, D. B. Longley, A systems biology approach identifies SART1 as a novel determinant of both 5-fluorouracil and SN38 drug resistance in colorectal cancer. Mol Cancer Ther 11, 119–131 (2012)

    CAS  Article  PubMed  Google Scholar 

  20. S. Nam, H. R. Chang, H. R. Jung, Y. Gim, N. Y. Kim, R. Grailhe, H. R. Seo, H. S. Park, C. Balch, J. Lee, A pathway-based approach for identifying biomarkers of tumor progression to trastuzumab-resistant breast cancer. Cancer Lett 356, 880–890 (2015)

    CAS  Article  PubMed  Google Scholar 

  21. C. Clarke, S. F. Madden, P. Doolan, S. T. Aherne, H. Joyce, L. O’Driscoll, W. M. Gallagher, B. T. Hennessy, M. Moriarty, J. Crown, Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis. Carcinogenesis 34, 2300–2308 (2013)

    CAS  Article  PubMed  Google Scholar 

  22. Giulietti M, Occhipinti G, Principato G, Piva F. Weighted gene co-expression network analysis reveals key genes involved in pancreatic ductal adenocarcinoma development. Cell. Oncol., 1–10 (2016)

  23. W. Liu, L. Li, W. Li, Gene co-expression analysis identifies common modules related to prognosis and drug resistance in cancer cell lines. Int J Cancer 135, 2795–2803 (2014)

    CAS  Article  PubMed  Google Scholar 

  24. S. Davis, P. S. Meltzer, GEOquery: a bridge between the Gene expression omnibus (GEO) and BioConductor. Bioinformatics 23, 1846–1847 (2007)

    Article  PubMed  Google Scholar 

  25. L. Gautier, L. Cope, B. M. Bolstad, R. A. Irizarry, Affy—analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20, 307–315 (2004)

    CAS  Article  PubMed  Google Scholar 

  26. W. Huber, A. Von Heydebreck, H. Sültmann, A. Poustka, M. Vingron, Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18, S96–S104 (2002)

    Article  PubMed  Google Scholar 

  27. P. Langfelder, S. Horvath, WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9, 559 (2008)

    Article  PubMed  PubMed Central  Google Scholar 

  28. L. Song, P. Langfelder, S. Horvath, Comparison of co-expression measures: mutual information, correlation, and model based indices. BMC Bioinformatics 13, 328 (2012)

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  29. A. M. Yip, S. Horvath, Gene network interconnectedness and the generalized topological overlap measure. BMC Bioinformatics 8, 22 (2007)

    Article  PubMed  PubMed Central  Google Scholar 

  30. Y. Choi, C. Kendziorski, Statistical methods for gene set co-expression analysis. Bioinformatics 25, 2780–2786 (2009)

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  31. Y. Rahmatallah, F. Emmert-Streib, G. Glazko, Gene sets net correlations analysis (GSNCA): a multivariate differential coexpression test for gene sets. Bioinformatics 30, 360–368 (2014)

    CAS  Article  PubMed  Google Scholar 

  32. P. Langfelder, S. Horvath, Eigengene networks for studying the relationships between co-expression modules. BMC Syst Biol 1, 54 (2007)

    Article  PubMed  PubMed Central  Google Scholar 

  33. S. Greenstein, K. Ghias, N. L. Krett, S. T. Rosen, Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies. Clin Cancer Res 8, 1681–1694 (2002)

    CAS  PubMed  Google Scholar 

  34. H. Han, H. Shim, D. Shin, J. E. Shim, Y. Ko, J. Shin, H. Kim, A. Cho, E. Kim, T. Lee, TRRUST: a reference database of human transcriptional regulatory interactions. Sci Rep UK 5 (2015)

  35. D. Stumpel, D. Schotte, E. Lange-Turenhout, P. Schneider, L. Seslija, R. De Menezes, V. Marquez, R. Pieters, M. Den Boer, R. Stam, Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: major matters at a micro scale. Leukemia 25, 429–439 (2011)

    CAS  Article  PubMed  Google Scholar 

  36. C.-H. Chou, N.-W. Chang, S. Shrestha, S.-D. Hsu, Y.-L. Lin, W.-H. Lee, C.-D. Yang, H.-C. Hong, T.-Y. Wei, S.-J. Tu, miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database. Nucl Acids Res 44, D239–D247 (2016)

    Article  PubMed  Google Scholar 

  37. Smyth GK. Limma: linear models for microarray data. Bioinformatics and computational biology solutions using R and Bioconductor: Springer, 397–420 (2005)

  38. P. Langfelder, R. Luo, M. C. Oldham, S. Horvath, Is my network module preserved and reproducible. PLoS Comput Biol 7, e1001057 (2011)

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  39. G. Dennis Jr., B. T. Sherman, D. A. Hosack, J. Yang, W. Gao, H. C. Lane, R. A. Lempicki, DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4, P3 (2003)

    Article  PubMed  Google Scholar 

  40. M. E. Smoot, K. Ono, J. Ruscheinski, P.-L. Wang, T. Ideker, Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27, 431–432 (2011)

    CAS  Article  PubMed  Google Scholar 

  41. M. Yang, P. Zeng, R. Kang, Y. Yu, L. Yang, D. Tang, L. Cao, S100A8 contributes to drug resistance by promoting autophagy in leukemia cells. PLoS One 9, e97242 (2014)

    Article  PubMed  PubMed Central  Google Scholar 

  42. J. Szczepanek, M. Pogorzala, M. Jarzab, M. Oczko-Wojciechowska, M. Kowalska, A. Tretyn, M. Wysocki, B. Jarzab, J. Styczynski, Expression profiles of signal transduction genes in ex vivo drug-resistant pediatric acute lymphoblastic leukemia. Anticancer Res 32, 503–506 (2012)

    CAS  PubMed  Google Scholar 

  43. K. Hu, Y. Gu, L. Lou, L. Liu, Y. Hu, B. Wang, Y. Luo, J. Shi, X. Yu, H. Huang, Galectin-3 mediates bone marrow microenvironment-induced drug resistance in acute leukemia cells via Wnt/β-catenin signaling pathway. J Hematol Oncol 8, 1 (2015)

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  44. M. Plander, P. Ugocsai, S. Seegers, E. Orsó, A. Reichle, G. Schmitz, F. Hofstädter, G. Brockhoff, Chronic lymphocytic leukemia cells induce anti-apoptotic effects of bone marrow stroma. Ann Hematol 90, 1381–1390 (2011)

    Article  PubMed  Google Scholar 

  45. K. De Bosscher, W. Vanden Berghe, L. Vermeulen, S. Plaisance, E. Boone, G. Haegeman, Glucocorticoids repress NF-kB-driven genes by disturbing the interaction of p 65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proc Natl Acad Sci U S A 97, 3919–3924 (2000)

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  46. K. Vazquez-Santillan, J. Melendez-Zajgla, L. Jimenez-Hernandez, G. Martínez-Ruiz, V. Maldonado, NF-κB signaling in cancer stem cells: a promising therapeutic target? Cell Oncol 38, 327–339 (2015)

    CAS  Article  Google Scholar 

  47. R. Thulasi, D. Harbour, E. Thompson, Suppression of c-myc is a critical step in glucocorticoid-induced human leukemic cell lysis. J Biol Chem 268, 18306–18312 (1993)

    CAS  PubMed  Google Scholar 

  48. D. J. Stumpel, P. Schneider, E. H. van Roon, J. M. Boer, P. de Lorenzo, M. G. Valsecchi, R. X. de Menezes, R. Pieters, R. W. Stam, Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options. Blood 114, 5490–5498 (2009)

    CAS  Article  PubMed  Google Scholar 

  49. A. Ferraro, Altered primary chromatin structures and their implications in cancer development. Cell Oncol 39, 1–16 (2016)

    Article  Google Scholar 

  50. V. Taucher, H. Mangge, J. Haybaeck, Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application. Cell Oncol 39, 1–24 (2016)

    Article  Google Scholar 

  51. M. Vitiello, A. Tuccoli, L. Poliseno, Long non-coding RNAs in cancer: implications for personalized therapy. Cell Oncol 38, 17–28 (2015)

    CAS  Article  Google Scholar 

Download references

Acknowledgments

The authors would like to thank the Center of High Performance Computing (CHPC), School of Mathematics, Statistics and Computer Science, College of Science, University of Tehran for providing their cluster to meet our computational needs. We would like to thank the anonymous reviewer/editor for scientific and English editing the manuscript.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Ali Masoudi-Nejad.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Human and animal rights and informed consent

This article does not contain any studies with human participants or animals performed by any of the authors.

Electronic supplementary material

Table S1

(DOCX 11 kb)

Table S2

(DOCX 13 kb)

Table S3

(DOCX 14 kb)

Table S4

(XLSX 21 kb)

Fig. S1

(DOCX 81 kb)

Fig. S2

(DOCX 59 kb)

Fig. S3

(DOCX 135 kb)

Fig. S4

(DOCX 468 kb)

Fig. S5

(DOCX 330 kb)

Fig. S6

(DOCX 37 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mousavian, Z., Nowzari-Dalini, A., Stam, R.W. et al. Network-based expression analysis reveals key genes related to glucocorticoid resistance in infant acute lymphoblastic leukemia. Cell Oncol. 40, 33–45 (2017). https://doi.org/10.1007/s13402-016-0303-7

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13402-016-0303-7

Keywords

  • Acute lymphoblastic leukemia
  • Glucocorticoid treatment
  • Drug resistance
  • Systems biology
  • Gene co-expression network